Document Detail

ABO blood group, hypercoagulability, and cardiovascular and cancer risk.
MedLine Citation:
PMID:  22856614     Owner:  NLM     Status:  Publisher    
The antigens of the ABO system (A, B, and H determinants, respectively) consist of complex carbohydrate molecules. It has been known for nearly half a century that the ABO blood group exerts a major influence on plasma levels of the von Willebrand factor (VWF)-factor VIII (FVIII) complex and that normal group O individuals have significantly lower levels of VWF and FVIII than do non-O individuals. As a consequence, several investigators have studied the association between ABO blood group and the risk of developing bleeding or thrombotic events. A number of epidemiological studies have also analyzed the biologic relevance of this interaction by assessing whether the ABO blood group could influence human longevity through the regulation of VWF-FVIII plasma levels. In this review, the molecular mechanisms by which the ABO blood group determines plasma VWF and consequently, FVIII levels, the possible clinical implications, and the current knowledge on the association between the ABO blood group and the risk of developing certain cancers will be reviewed.
Massimo Franchini; Emmanuel J Favaloro; Giovanni Targher; Giuseppe Lippi
Related Documents :
8672664 - Digital particle image velocimetry (dpiv) measurements of the velocity profiles through...
15335074 - A systematic analysis of a flow-switching modulator for comprehensive two-dimensional g...
11916594 - Measurement of volumetric mitral and aortic blood flow based on a new freehand three-di...
20308444 - Bicuspid aortic valve: four-dimensional mr evaluation of ascending aortic systolic flow...
23550954 - Performance on paced auditory serial addition test and cerebral blood flow in multiple ...
3619124 - Effects of pentoxifylline and prostaglandin e1 on cold blood perfusion studied by red b...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-3
Journal Detail:
Title:  Critical reviews in clinical laboratory sciences     Volume:  -     ISSN:  1549-781X     ISO Abbreviation:  Crit Rev Clin Lab Sci     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8914816     Medline TA:  Crit Rev Clin Lab Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Dipartimento di Medicina Trasfusionale ed Ematologia, Azienda Ospedaliera Carlo Poma , Mantova , Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Vibration response imaging: a novel noninvasive tool for evaluating the initial therapeutic effect o...
Next Document:  Social inhibition as a mediator of neuroticism and depression in the elderly.